Patents Assigned to HUVEPHARMA EOOD
  • CORONAVIRIDAE INFECTION AND AVERMECTINS
    Publication number: 20230111504
    Abstract: The present invention relates to new uses and methods of treatment. Specifically, the invention relates to new uses of Avermectins such as ivermectin for the treatment of Coronaviridae infection such as MERS, SARS or COVID-19 infection. In particular, the invention relates to new uses of Avermectins such as ivermectin for the treatment of COVID-19 infection.
    Type: Application
    Filed: May 21, 2021
    Publication date: April 13, 2023
    Applicant: Huvepharma EOOD
    Inventors: Kiril Petrov Domuschiev, Georgi Petrov Domuschiev
  • Thermostable phytases with high catalytic efficacy
    Patent number: 11241029
    Abstract: The present invention provides phytase enzymes exhibiting a surprisingly high thermostability as compared to commercially available phytases. Additionally some of the new phytase variants display up to four fold increased catalytic rate thus greatly increased speed of phytate dephosphorilation.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: February 8, 2022
    Assignee: HUVEPHARMA EOOD
    Inventors: Spas Bojidarov Petkov, Nikolay Stoyanov Outchkourov